Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lauren Bringman‐Rodenbarger"'
Publikováno v:
FASEB BioAdvances, Vol 2, Iss 5, Pp 286-295 (2020)
Abstract Electronic learning resources are popular with today's students. However, how students choose their favorite e‐learning resources is not well‐understood. The popular SecondLookTM histology self‐review tool was offered in three differen
Externí odkaz:
https://doaj.org/article/c38b03130ddc48a98b786202f1b36538
Publikováno v:
FASEB BioAdvances
FASEB BioAdvances, Vol 2, Iss 5, Pp 286-295 (2020)
FASEB BioAdvances, Vol 2, Iss 5, Pp 286-295 (2020)
Electronic learning resources are popular with today's students. However, how students choose their favorite e‐learning resources is not well‐understood. The popular SecondLook TM histology self‐review tool was offered in three different interf
Autor:
Miguel Rivera, Richard A. Sturm, Sophie Trefely, Peter Sajjakulnukit, Richard A. Scolyer, James S. Wilmott, Keith-Allen Melong, Sowmya Iyer, Costas A. Lyssiotis, Ho-Joon Lee, Min Wang, Andrei L. Osterman, Angela H. Guo, Surinder Kumar, Aleodor A. Andea, Ahmed Mostafa, H. Peter Soyer, Michelle Azar, Lauren Bringman-Rodenbarger, William Giblin, David B. Lombard, Zaneta Nikolovska-Coleska, Li Zhang, Douglas R. Fullen, Ahmed S.A. Mady, David Scott, Sriram Chandrasekaran, Mitchell S. Stark, Nathaniel W. Snyder, Carolina H Chung, Alexander C. Monovich, Marcus Bosenberg, Erika L. Varner, Antonia L. Pritchard, Namrata S Kadambi, Mary E. Skinner, Monique Verhaegen
Publikováno v:
J Clin Invest
Cutaneous melanoma remains the most lethal skin cancer, and ranks third among all malignancies in terms of years of life lost. Despite the advent of immune checkpoint and targeted therapies, only roughly half of patients with advanced melanoma achiev
Autor:
Richard A. Sturm, William Giblin, Lauren Bringman-Rodenbarger, Keith-Allen Melong, Aleodor A. Andea, H. Peter Soyer, Min Wang, Erika L. Varner, Michelle Azar, Miguel Rivera, Nathaniel W. Snyder, Zaneta Nikolovska-Coleska, Li Zhang, Namrata S Kadambi, Richard A. Scolyer, Carolina H Chung, Douglas R. Fullen, Mary E. Skinner, Marcus Bosenberg, Monique Verhaegen, James S. Wilmott, Ho-Joon Lee, David B. Lombard, David Scott, Ahmed S.A. Mady, Antonia L. Pritchard, Mitchell S. Stark, Angela Guo, Sowmya Iyer, Costas A. Lyssiotis, Andrei L. Osterman, Surinder Kumar, Ahmed M. Mostafa, Sriram Chandrasekaran, Peter Sajjakulnukit, Sophie Trefely
Cutaneous melanoma remains the most lethal skin cancer, and ranks third among all malignancies in terms of years of life lost. Despite the advent of immune checkpoint and targeted therapies, only roughly half of patients with advanced melanoma achiev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7553fe2a39083e450b5f4478a02122b
https://doi.org/10.1101/2020.09.07.286526
https://doi.org/10.1101/2020.09.07.286526
Significance: Developing evidence in the literature suggests that sirtuin 5 (SIRT5) may be involved in metabolic reprogramming, an emerging hallmark of cancer by which neoplastic cells reconfigure their metabolism to support the anabolic demands of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73240c9c9b3c6ce1470c30f124a8275c
https://europepmc.org/articles/PMC5824490/
https://europepmc.org/articles/PMC5824490/